Irish Food Stock News

ISE:KRZ
ISE:KRZFood

Kerry Group (ISE:KRZ) Valuation Check After Mixed Short And Long Term Share Price Performance

What recent performance tells you about Kerry Group Kerry Group (ISE:KRZ) has drawn attention after a mixed run in its share price, with a small 1 day decline alongside gains over the past week and month, but weaker returns over the past year. Over the past year, the stock shows a total return decline of about 20%, and the past 3 years and 5 years are also negative. In contrast, the past week and month are positive, while the past 3 months are slightly negative. On the fundamentals side,...
ISE:GL9
ISE:GL9Food

Is Glanbia (ISE:GL9) Still Attractive After Strong Multi‑Year Share Price Gains?

If you are wondering whether Glanbia’s current share price offers good value, it helps to look at how that price lines up with the fundamentals rather than just the headline moves. The stock most recently closed at €16.62, with returns of 1.8% over 7 days, 14.0% over 30 days, 14.8% year to date, 21.0% over 1 year, 60.5% over 3 years and 89.7% over 5 years. This may shape how you think about both upside and risk. Recent coverage around Glanbia has focused on its position within the food,...
ISE:RYA
ISE:RYAAirlines

Is It Too Late To Consider Ryanair Holdings (ISE:RYA) After Its Strong 1-Year Rally?

If you are wondering whether Ryanair Holdings is still good value after its recent run, this article explains what the current price might be implying about the stock. The share price closed at €28.84, with returns of 1.9% over 7 days, a 3.8% decline over 30 days, a 2.9% decline year to date, and a 42.9% return over 1 year, 96.6% over 3 years, and 102.4% over 5 years. Recent coverage has focused on how Ryanair fits into broader travel and aviation themes, with attention on capacity plans,...
ISE:RYA
ISE:RYAAirlines

Will Stronger Traffic Guidance Amid Weaker Quarterly Profit Change Ryanair Holdings' (ISE:RYA) Narrative

Ryanair Holdings plc recently reported past results for the quarter and nine months to December 31, 2025, showing higher revenue but a sharp quarterly net income drop versus a year earlier, alongside solid gains in year‑to‑date profit. At the same time, the airline raised its traffic guidance for fiscal 2026 and set expectations for further passenger growth into fiscal 2027, pointing to strong demand and earlier than expected Boeing aircraft deliveries as key drivers. Next, we examine how...
ISE:RYA
ISE:RYAAirlines

Ryanair Holdings (ISE:RYA) Valuation After Q3 Profit Hit From €256m Fine And Higher Traffic Guidance

Ryanair Holdings (ISE:RYA) is back in focus after third quarter earnings combined higher revenue with a sharp profit drop tied to a €256 million Italian competition fine, along with new guidance for passenger growth in 2026 and 2027. See our latest analysis for Ryanair Holdings. After this latest update, Ryanair’s share price of €28.29 sits slightly below where it started the year. Short term pressure from the Q3 profit hit contrasts with a stronger multi year total shareholder return profile...
ISE:GVR
ISE:GVRConsumer Durables

Glenveagh Properties (ISE:GVR) Valuation After New Share Buyback And 2,000 Unit Output Guidance

Glenveagh Properties (ISE:GVR) has put two clear signals on the table: a new share buyback of up to €25 million and guidance to scale homebuilding output to about 2,000 units by 2027. See our latest analysis for Glenveagh Properties. Those capital return and growth plans come after a solid stretch of gains, with the share price at €2.01 and a 90 day share price return of 10.93%. The 1 year total shareholder return sits at 30.52% and the 5 year total shareholder return is 136.47%, suggesting...
ISE:IRES
ISE:IRESResidential REITs

European Small Caps With Insider Action Highlighting Undervalued Opportunities

As the pan-European STOXX Europe 600 Index reaches new heights, buoyed by an improving economic backdrop and marking its strongest yearly performance since 2021, investors are increasingly focusing on small-cap opportunities within this dynamic market landscape. In such a thriving environment, identifying stocks with strong fundamentals and insider activity can highlight potential undervalued opportunities in the European small-cap sector.
ISE:UPR
ISE:UPRHealthcare

Is Uniphar’s Rare-Disease Logistics Expansion with Zevra Reshaping the Investment Case for Uniphar (ISE:UPR)?

Zevra Therapeutics announced that it has entered into an exclusive expanded access distribution agreement with Ireland-based Uniphar, enabling Niemann-Pick Disease Type C patients in select territories outside Europe to obtain reimbursed named-patient supply of MIPLYFFA, the only approved therapy that targets the underlying pathology of this ultra-rare condition. The deal strengthens Uniphar’s position as a specialist partner for complex rare-disease logistics, highlighting its capabilities...